392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
CorVel reported results for the quarter ended June 30, 2024, in a press release furnished as Exhibit 99.1. Revenue rose to $212 million from $190 million a year earlier, net income rose to $21.6 million from $19.8 million, and diluted earnings per share rose to $1.25 from $1.14. Revenue, profit and per-share earnings all improved year over year.
Revenue of $212 million for the quarter, up from $190 million in the June 2023 quarter
Diluted EPS of $1.25, compared with $1.14 a year earlier
Gross profit of $48.2 million at a 22.7% gross margin, up from $41.9 million
Repurchased $9.5 million of common stock; ended the quarter with $132 million in cash and no borrowings
NewMarket reported second-quarter 2024 net income of $111.6 million, or $11.63 per share, up from $99.6 million, or $10.36 per share, a year earlier. Total net sales rose to $710.2 million from $685.1 million, with the increase including its newly acquired AMPAC specialty materials business, while petroleum additives sales fell slightly. The results are a routine quarterly update, and the filing does not include new guidance.
Q2 2024 net income was $111.6 million, or $11.63 per share, versus $99.6 million, or $10.36 per share, in Q2 2023.
Petroleum additives operating profit was $147.8 million, up from $132.1 million, mainly due to lower raw material and operating costs and higher shipments, partly offset by lower selling prices.
Petroleum additives sales were $669.8 million, down from $684.0 million, while specialty materials (AMPAC) added $38.0 million in sales.
Net Debt to EBITDA was 1.6 as of June 30, 2024, after the AMPAC acquisition completed on January 16, 2024; long-term debt was $1.17 billion.
Centerspace reported second-quarter 2024 results and raised the midpoint of its 2024 Core FFO per diluted share outlook, narrowing the range to $4.78 to $4.92 from $4.74 to $4.92. Q2 net loss was $0.19 per diluted share, compared with a $0.23 loss a year earlier, while Core FFO per diluted share was $1.27 versus $1.28 in the prior-year quarter.
Updated 2024 Core FFO per diluted share outlook: $4.78 to $4.92, up from $4.74 to $4.92; net income per diluted share outlook raised to $(1.21) to $(1.01) from $(1.34) to $(1.10)
Q2 2024 net loss of $0.19 per diluted share vs. $0.23 loss in Q2 2023; Q2 Core FFO of $1.27 per diluted share vs. $1.28
Six-month Core FFO per diluted share rose 5.5% to $2.49; same-store NOI rose 2.4% in Q2 2024 year over year
Unsecured credit facility maturity extended to July 2028 on July 26, 2024; borrowing capacity stayed at $250.0 million
COPT Defense Properties reported results for the quarter ended June 30, 2024, with net income of $36.4 million, up from $31.6 million in the same quarter of 2023. Diluted FFO per share rose to $0.64 from $0.60, and the company's quarterly dividend per common share was $0.295, up from $0.285 a year earlier.
Q2 2024 total revenues were $187.3 million, compared with $169.2 million in Q2 2023.
Diluted EPS was $0.31, compared with $0.27 in Q2 2023. Net income was $36.4 million.
NOI from real estate operations was $105.4 million, compared with $95.0 million in Q2 2023.
Dividend per common share was $0.295 for the quarter, compared with $0.285 a year earlier.
CNO Financial Group reported second-quarter 2024 net income of $116.3 million, or $1.06 per diluted share, up from $73.7 million, or $0.64 per diluted share, a year earlier. Net operating income rose to $114.6 million, or $1.05 per diluted share, and the company said it is raising full-year guidance on earnings and cash flow. The company returned $77.2 million to shareholders in the quarter through buybacks and dividends.
Net income of $116.3 million, or $1.06 per diluted share, in 2Q24 versus $73.7 million, or $0.64, in 2Q23
Net operating income of $114.6 million, or $1.05 per diluted share, in 2Q24 versus $62.3 million, or $0.54, in 2Q23
Full-year guidance raised on earnings and cash flow
Repurchased $60.0 million of common stock in 2Q24; 106.5 million shares outstanding at June 30, 2024
Element Solutions reported second-quarter 2024 net sales of $613 million, up 5% from a year earlier, and net income of $93 million versus $30 million in the same quarter of 2023. GAAP diluted EPS was $0.38 compared with $0.11, and adjusted EBITDA rose 16% to $135 million. The company also said it raised its full-year 2024 adjusted EBITDA guidance to $530 million to $545 million, which supports the earnings trend for shareholders.
Net sales $613 million, up 5% reported and 4% organic; Electronics up 10% to $392 million
GAAP diluted EPS $0.38 vs $0.11; adjusted EPS $0.36 vs $0.31 a year earlier
Adjusted EBITDA $135 million, up 16%; Industrial & Specialty net sales down 4% to $221 million
Full-year 2024 adjusted EBITDA guidance raised to $530 million to $545 million; free cash flow expected $280 million to $300 million
Merchants Bancorp reported second quarter 2024 net income of $76.4 million, or $1.49 per diluted share, up 17% and 14% from the second quarter of 2023 but down 12% and 17% from the first quarter of 2024. Total assets reached $18.2 billion and tangible book value per share rose 30% year over year to $31.27.
Net income of $76.4 million, up 17% from $65.3 million a year earlier and down 12% from $87.1 million in Q1 2024
Diluted EPS of $1.49, up from $1.31 a year earlier and down from $1.80 in Q1 2024
Total assets of $18.2 billion at June 30, 2024; tangible book value per share of $31.27, up 30% from $24.14
Non-performing loans rose to $143.5 million, or 1.30% of gross loans, from $131.8 million (1.22%) at March 31, 2024
Corcept Therapeutics reported second-quarter 2024 revenue of $163.8 million, up 39% from a year earlier, and raised its full-year 2024 revenue guidance to $640 million to $670 million from $620 million to $650 million. Diluted earnings per share were $0.32, compared with $0.25 in the second quarter of 2023, though operating expenses rose to $128.2 million from $88.1 million.
Q2 2024 revenue of $163.8 million, versus $117.7 million in Q2 2023
Diluted EPS of $0.32 versus $0.25; net income of $35.5 million versus $27.5 million
2024 revenue guidance raised to $640 million to $670 million from $620 million to $650 million
Cash and investments of $492.5 million at June 30, 2024, up from $451.0 million at March 31, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.